Cardiothoracic & vascular anesthesia

Postoperative Pulmonary Artery Pulsatility Index Improves Prediction of Right Ventricular Failure After Left Ventricular Assist Device Implantation

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

The inclusion of postoperative PAPi offers more robust predictive power for right ventricular failure in patients undergoing durable LVAD implantation, compared with the use of existing risk scores alone.

Study context

Population
Adults undergoing durable left ventricular assist device (LVAD) implantation with CPB under GA and pulmonary artery catheter, tertiary academic centre, 2017–2019
Participants
67 adults
Exposure
Michigan score with vs without postoperative pulmonary artery pulsatility index (PAPi) for predicting right ventricular failure
Outcome
Right ventricular failure (composite:
  • Right ventricular mechanical circulatory support
  • Inhaled pulmonary vasodilator ≥48 h
  • Inotrope use ≥14 days or at discharge)
Methodological detailssingle-centre, observational
  • Single-centre
  • Observational

Main finding

As reported in the abstract

Right ventricular failure
Odds ratio (95% CI)
Preoperative transpulmonary gradient
1.15(1.02–1.28)
Preoperative cardiac index
0.83(0.71–0.98)
Postoperative PAPi
0.85(0.75–0.97)
Incidence of right ventricular failure
30% (n = 20)

Observational data: associations, not effects.

Further findings

OutcomeAUCP value
Predictive performance of Michigan score with vs without postoperative PAPi0.73 v 0.56P = 0.03
Predictive performance of Michigan score with vs without postoperative PAPi — Optimal cutoff for postoperative PAPi
1.56

Original publication

Postoperative Pulmonary Artery Pulsatility Index Improves Prediction of Right Ventricular Failure After Left Ventricular Assist Device Implantation. J Cardiothorac Vasc Anesth. Published 10 October 2023. doi:10.1053/j.jvca.2023.10.010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.